Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Oncopeptides AB

Closing information (x1000 DKK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 20,554 More Arrow 24,381 Less Arrow 5,583
Financial expenses 10,791 Less Arrow 3,886 Less Arrow 590
Earnings before taxes -184,582 More Arrow -166,876 Less Arrow -225,649
EBITDA -182,515 More Arrow -162,819 Less Arrow -221,966
Total assets 158,592 More Arrow 160,112 More Arrow 257,486
Current assets 140,985 Less Arrow 136,283 More Arrow 243,260
Current liabilities 33,353 Less Arrow 30,180 More Arrow 55,582
Equity capital 35,256 More Arrow 38,138 More Arrow 196,656
- share capital 15,529 Less Arrow 7,060 Less Arrow 7,002
Employees (average) 66 Less Arrow 52 More Arrow 57

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 22.2% More Arrow 23.8% More Arrow 76.4%
Turnover per employee 311 More Arrow 469 Less Arrow 98
Profit as a percentage of turnover -898.0% More Arrow -684.5% Less Arrow -4041.7%
Return on assets (ROA) -109.6% More Arrow -101.8% More Arrow -87.4%
Current ratio 422.7% More Arrow 451.6% Less Arrow 437.7%
Return on equity (ROE) -523.5% More Arrow -437.6% More Arrow -114.7%
Change turnover -3,021 More Arrow 18,769 Less Arrow -73,466
Change turnover % -13% More Arrow 334% Less Arrow -93%
Chg. No. of employees 14 Less Arrow -5 Less Arrow -172
Chg. No. of employees % 27% Less Arrow -9% Less Arrow -75%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.